01 / 12
Enquirer Consulting Group / Prepared for HemaSource, Inc
July 2026

New markets need motion.
Not just territory.

You asked us to send information, so we built this around the Blood and New Markets expansion you lead at HemaSource.
DesignBuildRunHand over
BUILDRUNOWN
Enquirer AI is the outbound engine of Enquirer Consulting Group
What we see

A broader footprint needs an always on new business motion.

01
HemaSource now has licensing across all 50 states following the Fountain Medical Supplies acquisition.
02
Blood, dialysis, IV hydration, and IV fluids each introduce distinct buyer groups to reach.
03
The visible foundation is strong in specialty distribution and recurring supply, while new-market outreach has room for a dedicated engine.
This is our read from the outside, to pressure-test together on a call, not a verdict.
Prepared for HemaSource, Inc
Where this goes

Turn expanded reach into a repeatable route to new accounts.

Today
.
New markets and new territory create more accounts to prioritize.
.
Relationship coverage alone cannot create consistent outreach across every segment.
In the first weeks and months
+
A clear named-account plan for the facilities that fit each new market.
+
A focused outbound motion that earns conversations with the right operators.
+
A working business unit HemaSource can take ownership of after it is proven.
Enquirer Consulting Group
How the engagement works

Build. Run. Own.

01 / BUILD

Build

We design, staff and stand up the complete unit. The named-account data, the messaging, the outbound engine, the automation and the reporting.

02 / RUN

Run

We run it in market for a fixed four months and prove it on real booked meetings, not slides. First conversations land early.

03 / OWN

Own

We hand over the playbook, the tooling, the dashboards and a trained operator. You own the engine.

One contractor, a network of specialists. One point of contact, and you never manage a stack of tools or freelancers.
We build it, run it in market, then hand you the keys
What we build for HemaSource, Inc

Build the engine around the markets Joe owns.

Market map

Define the blood, dialysis, IV hydration, and IV fluids accounts worth pursuing first.

Outbound unit

Build the messaging, workflow, and specialist coverage required to create qualified conversations.

Handover ready

Run the motion on real meetings, then leave HemaSource with the working engine and process.

The point is to give Blood and New Markets a repeatable way to open the accounts that fit HemaSource's expanded reach.
Enquirer Consulting Group
The engine, in plain terms

Every message, written for one real person.

01

Target

We would target decision makers at blood banks, blood drive operators, dialysis clinics, and IV infusion or hydration clinics that need recurring consumable supply and inventory support.

02

Personalize

AI reads each profile and writes a unique message. No templates.

03

Hand off warm

A positive reply pings you and your operator with the prospect and a way to reach them.

04

You take it from there

You take pre-qualified conversations. The engine handles everything before it.

Research-led and human-reviewed. Every message is on-brand, and most of the volume runs on capacity we operate, not only your account.
Enquirer AI is the outbound engine of Enquirer Consulting Group
Why this fits now

New markets deserve a dedicated route to demand.

01

Expanded territory

The Fountain acquisition opened nationwide licensing and added IV fluids to the offer.

02

Defined buyers

HemaSource serves specialty ambulatory facilities with recurring supply needs.

03

Clear ownership

Joe's Blood and New Markets remit gives the work a natural commercial home.

Enquirer Consulting Group
Proof, in the field

We have run this exact engine inside medical.

Tim Rath
Chief Operating Officer, Innovative Radiology
Enquirer AI helps us identify the right people and start the conversation in a much smarter way.
4 mo
A fixed build in market, then the system is yours to keep.
10+
Booked conversations on strong campaigns, in medical, from cold.
Innovative Radiology is a real medical client we ran this engine for. The figures come from strong campaigns and are not a promise of your numbers. We would agree your targets up front and prove against them.
Why ECG

You own it at the end. That is the difference.

+
Without building an outbound team from scratch.
+
Without a permanent agency on retainer forever.
+
Without a stack of tools and freelancers to manage.
+
Without lock-in. You own the engine, including the operator who runs it.
A freelancer sends emails. An agency rents you reps. A consultancy hands you a slide deck. We design the engine, staff it, run it, prove it on real meetings, then hand you the keys.
Enquirer Consulting Group
How we start

Stand up fast. Prove it. Then scale.

Stand up

Build

The named-account data, the messaging, the engine and the dashboard. Day-one capacity from warmed assets and managed seats.

Prove

The test

Run against the KPIs we agree up front. First meetings on the calendar early.

Scale

Ramp

Once the numbers hold, ramp the seats and breadth to the volume you want.

Own

Hand over

Playbook, tooling, dashboards and a trained operator. The engine is yours.

Onboarding sets the targeting and the voice first, so the outreach lands warmer every week.
Enquirer Consulting Group
Next step

Let's see if the mechanism fits.

  1. Matthew calls Joe at the number on file for a short fit conversation.
  2. Joe sanity-checks the first named-account list across blood, dialysis, IV hydration, and IV fluids.
  3. We decide whether there is a fit for a focused HemaSource outbound build.
Reply with two or three times that suit and we will work around you, or grab a slot at calendly.com/enquirer/review.
Enquirer AI is the outbound engine of Enquirer Consulting Group
Enquirer Consulting Group

We build it, run it in market, then hand you the keys.

Matthew   /   matthew@enquirerconsulting.com   /   calendly.com/enquirer/review
More about us at enquirerconsulting.com
Enquirer AI is the outbound engine of Enquirer Consulting Group. Prepared for HemaSource, Inc.